FSH receptor binding inhibitor influences estrogen production, receptor expression and signal pathway during in vitro maturation of sheep COCs

被引:9
|
作者
Gong Zhuandi [1 ]
Liang Haoqin [2 ]
Deng Yingying [2 ]
Lai Luju [2 ]
Wei Suocheng [2 ]
Zhaxi Yingpai [2 ]
Li You [2 ]
机构
[1] Northwest Minzu Univ, Med Coll, Lanzhou 730030, Gansu, Peoples R China
[2] Northwest Minzu Univ, Coll Life Sci & Engn, Lanzhou 730030, Gansu, Peoples R China
关键词
Oocyte; In vitro maturation; Estrogen receptor; FSH receptor binding inhibitor; Protein kinase A; GRANULOSA-CELLS; PROTEIN; PHOSPHORYLATION; ACTIVATION; CULTURE; OVARY; BETA;
D O I
10.1016/j.theriogenology.2017.06.027
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Follicle-stimulating hormone (FSH) promotes secretion of follicle fluid and follicle development. FSH acts via cognate FSH receptor (FSHR). It remains unknown whether the supplement of FSH-receptor binding inhibitor (FRBI) into the in vitro maturation (IVM)medium influence the estrogen receptor expression and signal pathway of oocytes in sheep. The present study aimed to investigate FRBI effects on inositol trisphosphate (IP3) of oocytes and protein kinase A (PICA) of sheep granulosa cells, further to elucidate the signal pathway of FRBI effects. Cumulus-oocyte complexes (COCs) were recovered from antral follicles. COCs were cultured for 24 h in the IVM medium supplemented with varying concentrations of FRBI (0, 10, 20, 30 and 40 mu g/mL) and FSH (10IU/mL). ELISA was used to measure the concentrations of estradiol (E2) and IP3 in the IVM medium. Western blotting was utilized to detect protein expression of ER beta of COCs and protein kinase A (PICA) of granulosa cells. The results showed IP3 concentrations of FRBI-3 and FRBI-4 groups were less than that of CG and FSH groups at 22 h and 24 h (P < 0.05). PICA levels of FRBI-3 and FRBI-4 groups were significantly less than that of CG and FSH group (P < 0.05 or P < 0.01). Expression levels of ER beta mRNA and protein of FRBI-treated groups were gradually decreased in comparison to CG and FSH group. The minimum value was detected in the FRBI-4 group. ER beta protein level of the FRBI-4 group was significantly less than that of FSH group (P < 0.05). E2 concentrations of FRBI-treated groups were elevated as compared to CG, with the highest increment of FRBI-2 group (P < 0.05). Our results revealed a higher dose of FRBI reduced IP3 production. FRBI could suppress slightly expression levels of ER beta mRNA and protein of COCs and PICA of granulosa cells, additionally increased E2 production of sheep COCs. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 50 条
  • [31] Leptin regulates estrogen receptor gene expression in ATDC5 cells through the extracellular signal regulated kinase signaling pathway
    Wang, Shan-Jin
    Li, Xin-Feng
    Jiang, Lei-Sheng
    Dai, Li-Yang
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2012, 113 (04) : 1323 - 1332
  • [32] Activation of the Signal Transducer and Activator of Transcription 3 Pathway Up-Regulates Estrogen Receptor-β Expression in Lung Adenocarcinoma Cells
    Wang, Hao-Chen
    Yeh, Hsuan-Heng
    Huang, Wei-Lun
    Lin, Chien-Chung
    Su, Wen-Pin
    Chen, Helen H. W.
    Lai, Wu-Wei
    Su, Wu-Chou
    MOLECULAR ENDOCRINOLOGY, 2011, 25 (07) : 1145 - 1158
  • [33] Treatment with aromatase inhibitor acts indirectly through the estrogen receptor pathway causing decreased junction plakoglobin mRNA expression and vaginal atrophy
    Kallak, Theodora K.
    Baumgart, Juliane
    Nilsson, Kerstin
    Poromaa, Inger Sundstrom
    Evers, Anneli Stavreus
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (12): : 1328 - 1328
  • [34] Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines
    Tong, D
    Czerwenka, K
    Sedlak, J
    Schneeberger, C
    Schiebel, I
    Concin, N
    Leodolter, S
    Zeillinger, R
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 56 (01) : 91 - 97
  • [35] Placental development during early pregnancy in sheep: estrogen and progesterone receptor messenger RNA expression in pregnancies derived from in vivo-produced and in vitro-produced embryos
    Reynolds, L. P.
    Haring, J. S.
    Johnson, M. L.
    Ashley, R. L.
    Redmer, D. A.
    Borowicz, P. P.
    Grazul-Bilska, A. T.
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2015, 53 : 60 - 69
  • [36] CHANGES IN GAMMA-AMINOBUTYRATE TYPE-A RECEPTOR SUBUNIT MESSENGER-RNAS, TRANSLATION PRODUCT EXPRESSION, AND RECEPTOR FUNCTION DURING NEURONAL MATURATION IN-VITRO
    ZHENG, TM
    ZHU, WJ
    PUIA, G
    VICINI, S
    GRAYSON, DR
    COSTA, E
    CARUNCHO, HJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) : 10952 - 10956
  • [37] Dose-dependent effects of luteinizing hormone and follicle stimulating hormone on in vitro maturation, apoptosis, secretion function and expression of follicle stimulating hormone receptor and luteinizing hormone receptor of sheep oocytes
    Wei, S.
    Deng, Y.
    Lai, L.
    Liang, H.
    Gong, Z.
    SOUTH AFRICAN JOURNAL OF ANIMAL SCIENCE, 2018, 48 (02) : 369 - 378
  • [38] Cumulus expansion, nuclear maturation and connexin 43, cyclooxygenase-2 and FSH receptor mRNA expression in equine cumulus-oocyte complexes cultured in vitro in the presence of FSH and precursors for hyaluronic acid synthesis
    Dell'Aquila M.E.
    Caillaud M.
    Maritato F.
    Martoriati A.
    Gérard N.
    Aiudi G.
    Minoia P.
    Goudet G.
    Reproductive Biology and Endocrinology, 2 (1)
  • [39] Immunohistochemical localization and mRNA expression of activin, inhibin, follistatin, and activin receptor in bovine cumulus-oocyte complexes during in vitro maturation
    Izadyar, F
    Dijkstra, G
    Van Tol, HTA
    van de Eljnden-Van Raaij, AJM
    Van den Hurk, R
    Colenbrander, B
    Bevers, MM
    MOLECULAR REPRODUCTION AND DEVELOPMENT, 1998, 49 (02) : 186 - 195
  • [40] Changes in the expression and binding properties of the estrogen receptor in MCF-7 breast cancer cells during growth inhibition by tamoxifen and cisplatin
    Angela M. Otto
    Sybilla Schubert
    Roland Netzker
    Cancer Chemotherapy and Pharmacology, 2001, 48 : 305 - 311